The cost-effectiveness of three new technologies to enhance Pap testing.
D054598:Blue Cross Blue Shield Insurance Plans; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D012680:Sensitivity and Specificity; D013048:Specimen Handling; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis*; D014626:Vaginal Smears / Q000191:economics / Q000295:instrumentation / Q000379:methods